Search for Clinical Trial Results
Mucopolysaccharidosis Type II - 80 Studies Found
Status | Study |
Recruiting |
Study Name: Biomarker for Hunter Disease Condition:
|
Recruiting |
Study Name: Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI Condition:
Date: 2015-05-05 Interventions: |
Not yet recruiting |
Study Name: Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I and II Condition:
Date: 2017-05-11 Interventions:
|
Terminated |
Study Name: Clinical Trial of Growth Hormone in MPS I, II, and VI Condition:
Interventions: Drug: Somatropin (DNA origin) The study starting dose of Nutropin AQ® will be 0.48 mg/kg/week divid |
Active, not recruiting |
Study Name: Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA) Condition: Sanfilippo Syndrome Date: 2011-02-16 Interventions:
|
Completed |
Study Name: A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA) Condition: Sanfilippo Syndrome Type A Date: 2010-01-11 Interventions: Other: assessment Physical, developmental, neurological, behavioral, and neurocognitive assessments |
Active, not recruiting |
Study Name: Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy Condition:
|
Completed |
Study Name: Intracerebral Gene Therapy for Sanfilippo Type A Syndrome Condition:
|
Completed |
Study Name: Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B) Condition: Sanfilippo Syndrome Type B Date: 2012-01-10 |